Daniel Schneider
Chief Executive Officer at PHOTOCURE ASA
Net worth: 508 182 $ as of 2024-03-30
Profile
Daniel Schneider is currently the President & Chief Executive Officer at Photocure ASA since 2018.
Prior to this, he worked as the General Manager at Ablynx NV.
He holds an MBA from the University of Washington and an undergraduate degree from St. Louis University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHOTOCURE ASA
0.37% | 2022-12-30 | 99,689 ( 0.37% ) | 508 182 $ | 2024-03-30 |
Daniel Schneider active positions
| Companies | Position | Start |
|---|---|---|
| PHOTOCURE ASA | Chief Executive Officer | 2018-10-31 |
Former positions of Daniel Schneider
| Companies | Position | End |
|---|---|---|
| ABLYNX | Chief Executive Officer | - |
Training of Daniel Schneider
| University of Washington | Masters Business Admin |
| St. Louis University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| Private companies | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Stock Market
- Insiders
- Daniel Schneider
